EAM
WST icon

Erste Asset Management’s West Pharmaceutical WST Stock Holding History

Erste Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
1,661
+909
+121% +$278K ﹤0.01% 493
2026
Q1 		$184K Hold
752
– – ﹤0.01% 565
2025
Q4 		$207K Buy
+752
New +$206K ﹤0.01% 547
2025
Q3 		– Sell
-6,600
Closed -$1.6M – 852
2025
Q2 		$1.44M Buy
+6,600
New +$1.41M 0.01% 435

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Erste Asset Management's WST Position: Q2 2026 in Review

Erste Asset Management increased its West Pharmaceutical (WST) stake by 121% in Q2 2026, buying an estimated $278K and bringing the position to 1,661 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Erste Asset Management first reported a position in WST in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.44M in Q2 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Erste Asset Management held 1,661 shares of West Pharmaceutical worth $589K as of Q2 2026.
  • Erste Asset Management bought 909 West Pharmaceutical shares in Q2 2026, an estimated $278K.
  • West Pharmaceutical made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #493 holding.
  • Erste Asset Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 4 quarters since.
  • Erste Asset Management's West Pharmaceutical position peaked at $1.44M in Q2 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.